Company: LENZ Therapeutics, Inc.

Form Type: 8-K

Filing Date: 2024-03-22

Corporate Action: Spin-off

Type: New

Accession Number: 000162828024012633

Comments: The document is about a merger rather than a spin-off.

Document Link: View Document